IP36-10: Real-World Outcomes of Enfortumab Vedotin in Patients with Advanced Urothelial Carcinoma Ineligible for Clinical Trials
Saturday, May 16, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract
Log in
See all the content and easy-to-use features by logging in or registering!